
Life sciences alive and well in the DACH region
This month saw a flurry of activity in the life sciences and medical equipment sector. Among the venture firms, TVM Capital was especially busy. Together with other backers, TVM has sold Direvo Biotech AG to Bayer HealthCare for approximately EUR210m, which it originally backed in 2001.
What is interesting is not only that Direvo was itself a spin-out from TVM-backed Evotec AG, but that Direvo's subsidiary Direvo Industrial Biotechnology GmbH had spun out prior to the sale and raised EUR8m in a first round of financing, with investors including TVM. This makes Direvo Industrial Biotechnology GmbH a third-generation part of TVM Capital's portfolio, showing how historical portfolio companies can hatch further investment opportunities. And to round it all off, TVM invested EUR4.5m alongside Wellington Partners in medical equipment company invendo medical GmbH.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater